Probiotic nomenclature matters

por Hill, C., Scott, K., Klaenhammer, T. R., Quigley, E., Sanders, M. E.
Publicado 2016

The PAC‐SYM questionnaire for chronic constipation: defining the minimal important difference

por Yiannakou, Y., Tack, J., Piessevaux, H., Dubois, D., Quigley, E. M. M., Ke, M. Y., Da Silva, S., Joseph, A., Kerstens, R.
Publicado 2017

Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory

por Kennedy, P. J., Clarke, G., O‘Neill, A., Groeger, J. A., Quigley, E. M. M., Shanahan, F., Cryan, J. F., Dinan, T. G.
Publicado 2014

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

por Tack, J, Camilleri, M, Chang, L, Chey, W D, Galligan, J J, Lacy, B E, Müller-Lissner, S, Quigley, E M M, Schuurkes, J, Maeyer, J H, Stanghellini, V
Publicado 2012

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies

por Barrios, D. M., Phillips, G. S., Geisler, A. N., Trelles, S. R., Markova, A., Noor, S. J., Quigley, E. A., Haliasos, H. C., Moy, A. P., Schram, A. M., Bromberg, J., Funt, S. A., Voss, M. H., Drilon, A., Hellmann, M. D., Comen, E. A., Narala, S., Patel, A. B., Wetzel, M., Jung, J. Y., Leung, D. Y. M., Lacouture, M. E.
Publicado 2021